Last reviewed · How we verify
Complicated appendicitis
Approved treatments
- Doribax · Shionogi
- Tygacil · Fresenius Kabi
Tygacil works by binding to the 30S ribosomal subunit of bacteria, preventing the aminoacyl-tRNA from binding and thereby inhibiting protein synthesis. - Tygacil · Pfizer
Tigecycline is a tetracycline class antibacterial agent. - Merrem · National Institutes of Health Clinical Center (CC)
- Merrem · Pfizer
Meropenem works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated appendicitis patent landscape — cliff calendar, originator estates, attackable patents
- Complicated appendicitis treatment landscape brief
- Complicated appendicitis treatment updates RSS
Frequently asked questions about Complicated appendicitis
What drugs treat Complicated appendicitis?
Tracked treatments include Doribax, Tygacil, Merrem.
What is the treatment for Complicated appendicitis?
Standard treatment for Complicated appendicitis includes Doribax, Tygacil, Merrem. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Complicated appendicitis patent cliff · Complicated appendicitis CI report
- Treatment: Doribax · Shionogi
- Treatment: Tygacil · Fresenius Kabi
- Treatment: Tygacil · Pfizer
- Treatment: Merrem · National Institutes of Health Clinical Center (CC)
- Treatment: Merrem · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing